Episode

Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

Podcast

Few & Far Between: How Biotech Gets Built

Published

Oct 28, 2025

Duration seconds

3676

Processing state

not_requested

Canonical source

https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences

Audio

https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2174119/c1e-x878rs9g961sxnj8r9-dmxxggonh6nr-qul8n0.mp4

JSON

/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences

Markdown

/podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences.md

Actions

• POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences. We’ll be covering a myriad of biotech topics, from “business athletes” to the role of the operating company in the drug development industry. We’ll also be premiering our lightning round - quick questions and inspired answers from our podcast guests. Okay, let’s start the podcast!